318 reports of this reaction
1.7% of all MISOPROSTOL reports
#16 most reported adverse reaction
EXPOSURE DURING PREGNANCY is the #16 most commonly reported adverse reaction for MISOPROSTOL, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 318 FDA adverse event reports linking MISOPROSTOL to EXPOSURE DURING PREGNANCY. This represents approximately 1.7% of all 18,857 adverse event reports for this drug.
Patients taking MISOPROSTOL who experience exposure during pregnancy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EXPOSURE DURING PREGNANCY is a less commonly reported adverse event for MISOPROSTOL, but still significant enough to appear in the safety profile.
In addition to exposure during pregnancy, the following adverse reactions have been reported for MISOPROSTOL:
The following drugs have also been linked to exposure during pregnancy in FDA adverse event reports:
EXPOSURE DURING PREGNANCY has been reported as an adverse event in 318 FDA reports for MISOPROSTOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
EXPOSURE DURING PREGNANCY accounts for approximately 1.7% of all adverse event reports for MISOPROSTOL, making it a notable side effect.
If you experience exposure during pregnancy while taking MISOPROSTOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.